Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
Top Cited Papers
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 355 (9218) , 1845-1850
- https://doi.org/10.1016/s0140-6736(00)02288-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999
- Antiviral prophylaxis and treatment in chickenpox: A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of InfectionJournal of Infection, 1998
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza ActivityJournal of the American Chemical Society, 1997
- Health Impact of Influenza in the United StatesPharmacoEconomics, 1996
- Use of Antivirals in Influenza in the Elderly: Prophylaxis and TherapyGerontology, 1996
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Effect of influenza B virus infection on human performance.BMJ, 1993
- Acute Respiratory Disease Associated with Influenza Epidemics in Houston, 1981-1983The Journal of Infectious Diseases, 1987
- Structure of the catalytic and antigenic sites in influenza virus neuraminidaseNature, 1983